XTL Biopharmaceuticals Ltd ADR Strategic Asset Allocation Index
XTL Biopharmaceuticals Ltd ADR strategic asset allocation index. XTL Biopharmaceuticals Ltd ADR (XTLB) has a Strategic Asset Allocation Index of 0.3% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $14.00K) total $14.00K, measured against net assets of $5.43 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See XTL Biopharmaceuticals Ltd ADR net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of XTL Biopharmaceuticals Ltd ADR (2003–2024)
Strategic asset allocation index of XTL Biopharmaceuticals Ltd ADR from 2003 to 2024. This chart shows how XTL Biopharmaceuticals Ltd ADR's Strategic Asset Allocation Index has evolved across 19 annual periods from 2003 to 2024. As of December 2024, the index stands at 0.3%, representing strategic assets of $14.00K against net assets of $5.43 Million USD. Check XTLB intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
XTL Biopharmaceuticals Ltd ADR Strategic Asset Allocation Index by Year (2003–2024)
XTL Biopharmaceuticals Ltd ADR strategic asset allocation index by year from 2003 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for XTL Biopharmaceuticals Ltd ADR from 2003 to 2024, covering 19 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see XTL Biopharmaceuticals Ltd ADR stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.3% | $14.00K | $- | $14.00K | $5.43 Million | ▲ +0.3 pp |
| 2023 | 0.0% | $0.00 | $- | $0.00 | $2.22 Million | ▼ 0.0 pp |
| 2021 | 0.0% | $1.00K | $1.00K | $- | $5.33 Million | ▼ 0.0 pp |
| 2020 | 0.0% | $2.00K | $2.00K | $- | $6.25 Million | ▲ +0.0 pp |
| 2019 | 0.0% | $2.00K | $2.00K | $- | $6.98 Million | ▼ -0.3 pp |
| 2016 | 0.4% | $10.00K | $10.00K | $- | $2.69 Million | ▲ +0.1 pp |
| 2015 | 0.2% | $11.00K | $11.00K | $- | $4.89 Million | ▼ -0.3 pp |
| 2014 | 0.5% | $24.00K | $24.00K | $- | $4.68 Million | ▼ -0.4 pp |
| 2013 | 0.9% | $61.00K | $61.00K | $- | $6.79 Million | ▲ +0.1 pp |
| 2012 | 0.8% | $72.00K | $72.00K | $- | $9.42 Million | ▼ -0.2 pp |
| 2011 | 0.9% | $32.00K | $32.00K | $- | $3.44 Million | ▼ -0.3 pp |
| 2010 | 1.2% | $35.00K | $35.00K | $- | $2.83 Million | ▼ -327.3 pp |
| 2009 | 328.6% | $23.00K | $23.00K | $- | $7.00K | ▲ +325.7 pp |
| 2008 | 2.9% | $41.00K | $41.00K | $- | $1.43 Million | ▲ +1.6 pp |
| 2007 | 1.2% | $106.00K | $106.00K | $- | $8.56 Million | ▼ -0.9 pp |
| 2006 | 2.2% | $490.00K | $490.00K | $- | $22.76 Million | ▼ -4.6 pp |
| 2005 | 6.8% | $762.00K | $762.00K | $- | $11.25 Million | ▲ +2.1 pp |
| 2004 | 4.6% | $908.00K | $908.00K | $- | $19.60 Million | ▼ -0.5 pp |
| 2003 | 5.1% | $1.05 Million | $1.05 Million | $- | $20.61 Million | — |